| 000 | 01569 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515072746.0 | ||
| 264 | 0 | _c20080221 | |
| 008 | 200802s 0 0 eng d | ||
| 022 | _a0022-3549 | ||
| 024 | 7 |
_a10.1002/jps.20877 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKatneni, Kasiram | |
| 245 | 0 | 0 |
_aUse of plasma proteins as solubilizing agents in in vitro permeability experiments: correction for unbound drug concentration using the reciprocal permeability approach. _h[electronic resource] |
| 260 |
_bJournal of pharmaceutical sciences _cJan 2008 |
||
| 300 |
_a209-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlbumins _xchemistry |
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Proteins _xchemistry |
| 650 | 0 | 4 |
_aCarrier Proteins _xdrug effects |
| 650 | 0 | 4 |
_aDiazepam _xchemistry |
| 650 | 0 | 4 |
_aDigoxin _xchemistry |
| 650 | 0 | 4 | _aExcipients |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOrosomucoid _xchemistry |
| 650 | 0 | 4 | _aPermeability |
| 650 | 0 | 4 |
_aPharmaceutical Preparations _xchemistry |
| 650 | 0 | 4 |
_aPropranolol _xchemistry |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aSurface-Active Agents |
| 650 | 0 | 4 | _aThermodynamics |
| 700 | 1 | _aCharman, Susan A | |
| 700 | 1 | _aPorter, Christopher J H | |
| 773 | 0 |
_tJournal of pharmaceutical sciences _gvol. 97 _gno. 1 _gp. 209-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jps.20877 _zAvailable from publisher's website |
| 999 |
_c17122698 _d17122698 |
||